Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2001 1
2002 7
2003 4
2004 5
2005 6
2006 12
2007 17
2008 17
2009 30
2010 24
2011 40
2012 24
2013 27
2014 30
2015 44
2016 28
2017 17
2018 17
2019 14
2020 4
2021 8
2022 5
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16026367

340 results
Results by year
Filters applied: . Clear all
Page 1
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*).
Yang W, Chen L, Ji Q, Liu X, Ma J, Tandon N, Bhattacharyya A, Kumar A, Kim KW, Yoon KH, Bech OM, Zychma M. Yang W, et al. Diabetes Obes Metab. 2011 Jan;13(1):81-8. doi: 10.1111/j.1463-1326.2010.01323.x. Diabetes Obes Metab. 2011. PMID: 21114607 Clinical Trial.
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR; NN2211-1310 International Study Group. Madsbad S, et al. Diabetes Care. 2004 Jun;27(6):1335-42. doi: 10.2337/diacare.27.6.1335. Diabetes Care. 2004. PMID: 15161785 Clinical Trial.
Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies.
Fujioka K, Brazg RL, Raz I, Bruce S, Joyal S, Swanink R, Pans M. Fujioka K, et al. Diabetes Obes Metab. 2005 Jan;7(1):28-39. doi: 10.1111/j.1463-1326.2004.00369.x. Diabetes Obes Metab. 2005. PMID: 15642073 Clinical Trial.
340 results